"Immunoglobulin G" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B.
| Descriptor ID |
D007074
|
| MeSH Number(s) |
D12.776.124.486.485.114.619.393 D12.776.124.790.651.114.619.393 D12.776.377.715.548.114.619.393
|
| Concept/Terms |
IgG(T)- IgG(T)
- Immunoglobulin GT
- GT, Immunoglobulin
|
Below are MeSH descriptors whose meaning is more general than "Immunoglobulin G".
Below are MeSH descriptors whose meaning is more specific than "Immunoglobulin G".
This graph shows the total number of publications written about "Immunoglobulin G" by people in this website by year, and whether "Immunoglobulin G" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 2 | 2 |
| 1997 | 2 | 1 | 3 |
| 1998 | 0 | 7 | 7 |
| 1999 | 0 | 2 | 2 |
| 2000 | 1 | 0 | 1 |
| 2001 | 0 | 3 | 3 |
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 6 | 7 |
| 2004 | 6 | 29 | 35 |
| 2005 | 8 | 16 | 24 |
| 2006 | 2 | 13 | 15 |
| 2007 | 1 | 9 | 10 |
| 2008 | 1 | 5 | 6 |
| 2009 | 3 | 6 | 9 |
| 2010 | 0 | 5 | 5 |
| 2011 | 4 | 7 | 11 |
| 2012 | 1 | 7 | 8 |
| 2013 | 0 | 12 | 12 |
| 2014 | 4 | 15 | 19 |
| 2015 | 3 | 13 | 16 |
| 2016 | 8 | 15 | 23 |
| 2017 | 82 | 175 | 257 |
| 2018 | 76 | 149 | 225 |
| 2019 | 31 | 78 | 109 |
| 2020 | 117 | 258 | 375 |
| 2021 | 118 | 320 | 438 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunoglobulin G" by people in Profiles.
-
Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS-CoV-2 Vaccination. Arthritis Rheumatol. 2022 02; 74(2):284-294.
-
Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against COVID-19 (CoviVac) in preclinical studies. Emerg Microbes Infect. 2021 Dec; 10(1):1790-1806.
-
Association of Vaccine Type and Prior SARS-CoV-2 Infection With Symptoms and Antibody Measurements Following Vaccination Among Health Care Workers. JAMA Intern Med. 2021 12 01; 181(12):1660-1662.
-
Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries. J Infect Dis. 2021 11 16; 224(9):1462-1472.
-
Determinants and Dynamics of SARS-CoV-2 Infection in a Diverse Population: 6-Month Evaluation of a Prospective Cohort Study. J Infect Dis. 2021 10 28; 224(8):1345-1356.
-
Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients. Inflamm Bowel Dis. 2021 10 20; 27(11):1862-1864.
-
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19. J Intern Med. 2022 01; 291(1):72-80.
-
Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: Prospective observational study. J Med Virol. 2022 01; 94(1):279-286.
-
A high-throughput microsphere-based immunoassay of anti-SARS-CoV-2 IgM testing for COVID-19 diagnostics. PLoS One. 2021; 16(9):e0248444.
-
Self-collection of capillary blood using Tasso-SST devices for Anti-SARS-CoV-2 IgG antibody testing. PLoS One. 2021; 16(9):e0255841.